NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares ยท Health Care ยท NASDAQ
$30.82
โฒ $0.99 (+3.32%)
Market cap
$3.5B
52-week range
$17.63 โ $42.20
Volume
2.0M
Previous close
$29.83
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is held by 4 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: MAVERICK CAPITAL LTD.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| MAVERICK CAPITAL LTD Lee Ainslie |
0.8% | 2.2M | $70M | โฒ 15% (+292K) | $25.70 | 2026-03-31 |
| Castle Hook Partners LP Castle Hook Partners LP |
0.1% | 1.0M | $33M | โผ 3.9% (โ42K) | $35.08 | 2026-03-31 |
| Slate Path Capital LP David Greenspan |
0.1% | 319K | $10M | โ | $25.70 | 2026-03-31 |
| Duquesne Family Office Stanley Druckenmiller |
2.9% | 3.1M | $98K | โ | $0.02 | 2026-03-31 |
FAQ โพ
Which hedge funds hold NAMS?
Tracked holders include: MAVERICK CAPITAL LTD, Castle Hook Partners LP, Slate Path Capital LP, Duquesne Family Office.
How much smart money owns NAMS?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading NAMS?
No tracked Congressional trades in NAMS on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.